European Companies Search Engine

EU funding (€10.5M): INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH II Hor11 May 2026 EU Research and Innovation programme "Horizon"

Text

INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH II

ISIDORe II (Integrated Services for Infectious Disease Outbreak Research II) represents the strategic continuation of ISIDORe. Building on its proven capacity to mobilise Europe’s research infrastructures (RIs) for pandemic preparedness and response (PP&R) research, ISIDORe II consolidates the model into a leaner, strategically aligned consortium that enhances agility, coherence, and sustainability. Infectious disease–focused RIs form the operational backbone, ensuring depth in epidemic- and pandemic-relevant science, while transversal RIs provide enabling technologies such as imaging, omics, and structural biology. This integrated architecture ensures that Europe’s RI landscape delivers high-quality, challenge-driven, and interoperable services. ISIDORe II pursues three overarching missions: (1) deliver excellent RI services for PP&R research and empower users through a curated service catalogue, an interoperable digital platform, and inclusive outreach; (2) amplify impact by enabling scientific excellence, innovation, and data stewardship, accelerating medical countermeasure (MCM) development, embedding FAIR principles, and aligning with European Open Science policies; and (3) anchor the ISIDORe model within the EU and global preparedness ecosystem through coordination with actors such as HERA, ECDC, WHO, and DURABLE, while developing a stakeholder-validated sustainability plan. By offering a coherent, strategically sharpened model for transnational and virtual access (TNA/VA), ISIDORe II ensures that users benefit from comprehensive support, including ethics, biosafety, and regulatory guidance, alongside interoperable data practices. Its activities generate scientific excellence, policy-relevant evidence, and long-term impact for European and global health security. As the natural continuation of ISIDORe, ISIDORe II transforms a successful pilot into a sustainable cornerstone of the European preparedness and response landscape.


Funded Companies:

Company name Funding amount
Agencia Estatal Consejo Superior de Investigaciones Cientificas €0.00
Assistance Publique Hopitaux de Paris €10,000.00
Bernhard-Nocht-Institut Fuer Tropenmedizin €0.00
Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) €245,375
Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna Institucia €0.00
Centre National de la Recherche Scientifique CNRS €0.00
Ceske Vysoke Uceni Technicke V Praze €0.00
Charite - Universitaetsmedizin Berlin €0.00
Consiglio Nazionale Delle Ricerche €0.00
Department of Health €0.00
Eatris Eric €505,313
Ecrin European Clinical Research Infrastructure Network €100,313
Eidgenoessisches Departement DES Innern €10,000.00
Erasmus Universitair Medisch Centrum Rotterdam €0.00
Euro-Bioimaging Eric €325,675
European Infrastructure OF Open Screening Platforms FOR Chemical Biology European Research Infrastucture Consortium (EU-Openscreen Eric) €491,250
European Molecular Biology Laboratory €295,755
European Research Infrastructure ON Highly Pathogenic Agents €5,963,125
European Vaccine Initiative e. V. €296,250
European Virus Archive Aisbl €634,146
Folkhalsomyndigheten €0.00
Friedrich Loeffler Institut - Bundesforschungsinstitut Fuer Tiergesundheit €10,000.00
Fundacao Gimm - Gulbenkian Institute For Molecular Medicine €0.00
Fundacion Centro de Excelencia en Investigacion de Medicamentos Innovadores en Andalucia €0.00
Hellenic Pasteur Institute €0.00
Helmholtz-Zentrum FUR Infektionsforschung GmbH €10,000.00
Helsingin Yliopisto €0.00
Infrafrontier Eric €297,750
Institut de Investigacio en Ciencies de La Salut Germans Trias i Pujol €0.00
Institut de Recerca i Tecnologia Agroalimentaries €10,000.00
Institut National de la Sante et de la Recherche Medicale €0.00
Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement €679,983
Instituto de Biologia Experimental e Tecnologica €10,000.00
Instituto de Salud Carlos III €0.00
Instituto Nacional de Saude DR. Ricardo Jorge €0.00
Institut Pasteur €0.00
Instruct-Eric €511,563
Istituto Nazionale Per LE Malattie Infettive Lazzaro Spallanzani-Istituto Di Ricovero E Cura A Carattere Scientifico €0.00
Istituto Superiore Di Sanita €0.00
Istituto Zooprofilattico Sperimentale Della Lombardia E Dell'Emilia Romagna Bruno Ubertini €0.00
Istituto Zooprofilattico Sperimentale Delle Venezie €0.00
Karolinska Institutet €0.00
Katholieke Universiteit Leuven €0.00
Latvijas Organiskas Sintezes Instituts €0.00
Mediterranee Infection €10,000.00
Medizinische Universitat Graz €0.00
Nemzeti Nepegeszsegugyi ES Gyogyszereszeti Kozpont €0.00
Oslo Universitetssykehus HF €0.00
Rijksinstituut Voor Volksgezondheid EN Milieu (Rivm) €0.00
Statens Serum Institut €10,000.00
Stichting Biomedical Primate Research Center €10,000.00
Stichting Wageningen Research €10,000.00
The Chancellor, Masters and Scholars of the University of Oxford €0.00
The Secretary of State for Environment, Food and Rural Affairs €0.00
Universitat Basel €0.00
Universite d'AIX Marseille €0.00
Universitetet I Tromsoe - Norges Arktiske Universitet €0.00
Univerza V Ljubljani €0.00
Ustav Molekularni Genetiky AV CR V.V.I. €0.00
Vaccine Formulation Institute(CH)Ltd. €10,000.00

Source: https://cordis.europa.eu/project/id/101293306

The filing refers to a past date, and does not necessarily reflect the current state.